Insightec announced today that it received additional FDA approval for treating essential tremor with its Exablate Neuro platform. Essential tremor commonly affects both sides of the body, Insightec noted in a news release. The new approval allows appropriate patients to receive treatment on their second side at least nine months after treatment of the first side.
FDA Grants New Approval for Essential Tremor Treatment from Insightec
Posted on December 21, 2022
Categories: In the News